Burkina Faso slashes medicine prices in landmark health reform

The Burkina Faso government has unveiled an unprecedented reduction in the cost of essential generic medications and select medical supplies, with price cuts as steep as 72%. This bold initiative, backed by a 3 billion FCFA financial commitment, is set to take effect on March 1, 2026, aiming to democratize access to healthcare nationwide.

Following a Council of Ministers meeting on February 12, 2026, authorities announced sweeping price adjustments for essential generics, specialized health products, and medical consumables distributed through the Central Purchasing Agency for Essential Generics (CAMEG). The reform targets significant relief for households grappling with healthcare expenses.

Dr. Robert Lucien Jean-Claude Kargougou, Minister of Health, outlined the extent of the reductions: up to 67.27% for certain tablet formulations, 53.47% for injectable medications, 20% for syrups and suspensions, and a staggering 72.73% for specific medical consumables. These measures are designed to alleviate financial burdens on families while fostering equitable access to medical treatments.

The government’s financial outlay of 3 billion FCFA underscores its dedication to sustainable healthcare reform. This follows a prior price adjustment in May 2025, which yielded an estimated 5 billion FCFA in savings for households. Together, these policies reflect Burkina Faso’s commitment to delivering quality, affordable healthcare to all citizens.